Poland· PL-100059088
Rutinoscorbin
A rutosid, kombinationen product containing rutosidum trihydricum + acidum ascorbicum, registered in Poland by Haleon Poland Sp. z o.o.. The same ATC class is registered in 3 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Rutosid, kombinationen is registered in 3 of 19 countries.
Countries holding a registration under ATC C05CA51 (rutosid, kombinationen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Rutosid, kombinationen · ATC C05CA51
3 / 19 countries
- Czechiaprice
- Netherlands
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Rutosidum trihydricum + Acidum ascorbicum
- Manufacturer
- Haleon Poland Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- C05CA51
- ATC class
- Rutosid, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 9
- gtin05909990149711
- gtin05909990149728
- gtin05909990149735
- gtin05909990149742
- gtin05909990149759
- gtin05909990863624
- gtin05909990863631
- gtin05909990863648
- gtin05909990863655
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under C05CA51
Rutosid, kombinationen, as other registers publish it.
- CzechiaASCORUTINZentiva a.s., Bratislava
- CzechiaASCORUTINZentiva a.s., Bratislava
- CzechiaASCORUTINZentiva a.s., Bratislava
- PolandCerutinPolfarmex S.A.
- CzechiaCYCLO 3 FORTPIERRE FABRE MEDICAMENT, Lavaur
- CzechiaCYCLO 3 FORTPIERRE FABRE MEDICAMENT, Lavaur
- CzechiaCYCLO 3 FORTPIERRE FABRE MEDICAMENT, Lavaur
- NetherlandsVenoruton tabletten 500Healthypharm B.V.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Hungary · Ruta-C
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/63dc8ecc-888b-470d-8bab-824ed49ed746 GET /v1/drugs/63dc8ecc-888b-470d-8bab-824ed49ed746?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "25 mg + 100 mg",
"packaging": "05909990149711 ¦ OTC ¦ Skasowane ¦ 8807\n30 tabl.\n05909990149728 ¦ OTC ¦ 17090\n60 tabl.\n05909990149735 ¦ OTC ¦ 17091\n90 tabl.\n05909990149742 ¦ OTC ¦ 20085\n30 tabl.\n05909990149759 ¦ OTC ¦ 24154\n20 tabl.\n05909990863624 ¦ OTC ¦ 41588\n120 tabl.\n05909990863631 ¦ OTC ¦ 41741\n150 tabl.\n05909990863648 ¦ OTC ¦ 60964\n180 tabl.\n05909990863655 ¦ OTC ¦ 61364\n210 tabl.",
"substance": "Rutosidum trihydricum 25 mg + Acidum ascorbicum 100 mg",
"common_name": "Rutosidum trihydricum + Acidum ascorbicum",
"pl_product_id": "100059088",
"pozwolenie_nr": "01497",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about rutosid, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.